{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:59:05Z","timestamp":1793782745689,"version":"4.6.1"},"reference-count":63,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"GlaxoSmithKline Biologicals SA. GlaxoSmithKline"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2023,1,2]]},"DOI":"10.1080\/21645515.2023.2191575","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T23:28:40Z","timestamp":1681946920000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and\/or under 1500 g: A systematic literature review"],"prefix":"10.1080","volume":"19","author":[{"given":"Markus","family":"Knuf","sequence":"first","affiliation":[{"name":"Children\u2019s Hospital Worms","place":["Worms, Germany"]},{"name":"University of Medicine","place":["Mainz, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6972-3608","authenticated-orcid":false,"given":"Marie-Laure","family":"Charkaluk","sequence":"additional","affiliation":[{"name":"Saint Vincent de Paul Hospital, GHICL","place":["Lille, France"]},{"name":"Universit\u00e9 Catholique de Lille","place":["Lille, France"]},{"name":"Universit\u00e9 Paris Cit\u00e9","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2444-1786","authenticated-orcid":false,"given":"Phung Nguyen","family":"The Nguyen","sequence":"additional","affiliation":[{"name":"University of Medicine and Pharmacy","place":["Ho Chi Minh City, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0561-9913","authenticated-orcid":false,"given":"Ignacio","family":"Salamanca de la Cueva","sequence":"additional","affiliation":[{"name":"Grupo Instituto Hispalense de Pediatr\u00eda","place":["Sevilla, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"K\u00f6brunner","sequence":"additional","affiliation":[{"name":"Pallas Health Research and Consultancy","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Mason","sequence":"additional","affiliation":[{"name":"Pallas Health Research and Consultancy","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurine","family":"Duchenne","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline Pharmaceuticals SA\/NV","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Berlaimont","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline Pharmaceuticals SA\/NV","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-777X.77298"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2016.1205492"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.06.063"},{"key":"e_1_3_4_5_1","unstructured":"World Health Organization. DT-based combined vaccines. World Health Organization. [Accessed 2022 Jul 22]. https:\/\/www.who.int\/teams\/health-product-policy-and-standards\/standards-and-specifications\/vaccine-standardization\/dt-based-combined-vaccines."},{"issue":"2","key":"e_1_3_4_6_1","first-page":"E107","article-title":"Hexavalent vaccines: characteristics of available products and practical considerations from a panel of Italian experts","volume":"59","author":"Orsi A","year":"2018","unstructured":"Orsi A, Azzari C, Bozzola E, Chiamenti G, Chirico G, Esposito S, Francia F, Lopalco P, Prato R, Russo R, et al. Hexavalent vaccines: characteristics of available products and practical considerations from a panel of Italian experts. J Prev Med Hyg. 2018;59(2):E107\u201319.","journal-title":"J Prev Med Hyg"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-019-0742-7"},{"key":"e_1_3_4_8_1","unstructured":"Aronsson B Flor\u00e9n CC Greve-Isdahl M Lindstrand A N\u00f8kleby H Riise \u00d8 Stors\u00e6ter J Vestrheim DF Watle SV. Vaccination of preterm infants against pertussis and pneumococci. Immunogenicity effectiveness and safety. Oslo (Norway): Norwegian Institute of Public Health; 2018 [accessed 2022 Jul 20]. https:\/\/www.fhi.no\/globalassets\/dokumenterfiler\/rapporter\/vaksine\/vaccination-of-preterm-infants-against-pertussis-and-pneumococci_web.pdf."},{"key":"e_1_3_4_9_1","unstructured":"World Health Organization. Preterm birth; 2018 [accessed 2022 Sep 7]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/preterm-birth."},{"key":"e_1_3_4_10_1","unstructured":"World Health Organization. Global nutrition targets 2025: low birth weight policy brief. Geneva (Swizerland): World Health Organization; 2014 [accessed 2022 Jul 22]. https:\/\/www.who.int\/publications\/i\/item\/WHO-NMH-NHD-14.5."},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-112"},{"key":"e_1_3_4_12_1","volume-title":"The partnership for maternal, newborn and child health, save the children, World Health Organization. Born too soon: the global action report on preterm birth","author":"March of Dimes","year":"2012","unstructured":"March of Dimes. The partnership for maternal, newborn and child health, save the children, World Health Organization. Born too soon: the global action report on preterm birth. Geneva: World Health Organization; 2012."},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2017.46"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61698-6"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.6.6.12008"},{"key":"e_1_3_4_16_1","first-page":"313","volume-title":"Preterm birth: causes, consequences, and prevention","author":"Chapter 10","year":"2007","unstructured":"Chapter 10. Mortality and acute complications in preterm infants. In: Behrman RE, Butler AS, editors. Preterm birth: causes, consequences, and prevention. Washington (DC): National Academies Press (US); 2007. p. 313\u201345."},{"key":"e_1_3_4_17_1","unstructured":"Government of Canada. Immunization of infants born prematurely: Canadian immunization guide; 2015 [accessed 2022 Jul 18]. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-3-vaccination-specific-populations\/page-5-immunization-infants-born-prematurely.html."},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1074358"},{"key":"e_1_3_4_19_1","unstructured":"Minist\u00e8re de la Sant\u00e9 et de la Pr\u00e9vention. Calendrier des vaccinations et recommandations vaccinales 2022 [Vaccination schedule and vaccine recommendations 2022]. Paris (France): Minist\u00e8re de la Sant\u00e9 et de la Pr\u00e9vention; 2022 [accessed 2022 Jul 20]. https:\/\/solidarites-sante.gouv.fr\/IMG\/pdf\/calendrier_vaccinal_2022_mis_a_jour_juin_2022_v2.pdf."},{"key":"e_1_3_4_20_1","unstructured":"Robert Koch Institute. Immunization schedule. Recommendations of the standing committee on vaccination (STIKO) 2022. Berlin (Germany): Robert Koch Institute; 2022 [accessed 2022 Jul 20]. https:\/\/www.rki.de\/DE\/Content\/Infekt\/Impfen\/Materialien\/Downloads-Impfkalender\/Impfkalender_Englisch.pdf?__blob=publicationFile."},{"key":"e_1_3_4_21_1","unstructured":"Public Health Agency of Sweden. Vaccination av f\u00f6r tidigt f\u00f6dda barn [Vaccination of premature babies]. Solna (Sweden): Public Health Agency of Sweden. [Accessed 2022 Sep 8]. https:\/\/www.folkhalsomyndigheten.se\/smittskydd-beredskap\/vaccinationer\/rekommendationer-for-vaccination\/vaccination-av-prematura-barn\/#:~:text=F%C3%B6rsta%20dosen%20vaccin%20mot%20rotavirusinfektion vaccin%20mot%20rotavirusinfektion%20p%C3%A5%20neonatalavdelningen."},{"key":"e_1_3_4_22_1","unstructured":"Conseil Sup\u00e9rieur de la Sant\u00e9 de Belgique. Pr\u00e9matur\u00e9s: aspects sp\u00e9cifiques de la vaccination [Premature infants: specific aspects of vaccination]; 2014 [accessed 2022 Sep 8]. https:\/\/www.vaxinfopro.be\/spip.php?article1066&lang=fr&retour=1."},{"key":"e_1_3_4_23_1","unstructured":"Public Health England. Updated schedule for 2020. A quick guide to childhood immunisations for the parents of premature babies born on or after 1 January 2020; 2019 [accessed 2022 Jul 21]. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/849306\/PHE_11490_premature_quickguide_Jan2020.pdf."},{"key":"e_1_3_4_24_1","unstructured":"Centers for Disease Control and Prevention. Special Situations. General best practice guidelines for immunization: best practices guidance of the Advisory Committee on Immunization Practices (ACIP). Atlanta (GA USA): National Center for Immunization and Respiratory Diseases; 2022 [accessed 2022 Jul 19]. https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/special-situations.html."},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.112.1.193"},{"key":"e_1_3_4_26_1","unstructured":"State of Israel. Ministry of health. Vaccines for premature babies. Israel: Ministry of Health. [Accessed 2022 Jul 19]. https:\/\/www.health.gov.il\/English\/Topics\/Pregnancy\/Vaccination_of_infants\/Pages\/vaccine_premature_baby.aspx."},{"key":"e_1_3_4_27_1","unstructured":"Health Strategy and Policy Institute. Quy\u1ebft \u0111\u1ecbnh 2470\/Q\u0110-BYT h\u01b0\u1edbng d\u1eabn kh\u00e1m s\u00e0ng l\u1ecdc tr\u01b0\u1edbc ti\u00eam ch\u1ee7ng \u0111\u1ed1i v\u1edbi tr\u1ebb em [Decision 2470\/QD-BYT guiding pre-vaccination screening for children]. Hanoi (Vietnam): Institute of Health Strategy and Policy; 2019 [accessed 2022 Sep 6]. http:\/\/www.hspi.org.vn\/vcl\/Decision%202470%20\/%20QD-BYT%20Vietnamese%20Ministry%20of%20Health%20guiding%20pre-vaccination%20screening%20checks%20for%20children.%20em-t98-8951.html."},{"key":"e_1_3_4_28_1","unstructured":"Australian Government. Department of health and aged care. Vaccination for preterm infants; 2020 [accessed 2022 Jul 18]. https:\/\/immunisationhandbook.health.gov.au\/contents\/vaccination-for-special-risk-groups\/vaccination-for-preterm-infants."},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1840255"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1086\/649590"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.592731"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-6-20"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.11.014"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182293a82"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pepo.2017.05.008"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.09.065"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/802503"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2008.00884.x"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2008.03.043"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2009.112"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-1184"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1247586"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-021-04219-4"},{"key":"e_1_3_4_46_1","unstructured":"Grupo de trabajo vacunaci\u00f3n en prematuros de la Ponencia de Programa y Registro de Vacunaciones. Vacunaci\u00f3n en prematuros [Vaccination of preterm infants]; 2019 [accessed 2022 Nov 7]. https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/enfermedades\/docs\/Vacunacion_Prematuros.pdf."},{"key":"e_1_3_4_47_1","unstructured":"European Centre for Disease Prevention and Control. Vaccine scheduler. Poland: Recommended vaccinations. [Accessed 2022 Jul 21]. https:\/\/vaccine-schedule.ecdc.europa.eu\/Scheduler\/ByCountry?SelectedCountryId=166&IncludeChildAgeGroup=true&IncludeChildAgeGroup=false&IncludeAdultAgeGroup=true&IncludeAdultAgeGroup=false."},{"key":"e_1_3_4_48_1","unstructured":"Ministry of Health Viet Nam. National expanded program on immunization. Comprehensive multi-year plan cMYP for extended program on immunization 2016-2020. Hanoi (Vietnam): World Health Organization\/Ministry of Health Viet Nam; 2015 [accessed 2022 Nov 10]. https:\/\/extranet.who.int\/countryplanningcycles\/sites\/default\/files\/planning_cycle_repository\/viet_nam\/cmyp_vietnam_2016-2020.pdf."},{"key":"e_1_3_4_49_1","unstructured":"European Centre for Disease Prevention and Control. Vaccine scheduler. Vaccine schedules in all countries in the EU\/EEA. [Accessed 2022 Jul 21]. https:\/\/vaccine-schedule.ecdc.europa.eu\/."},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcped.2014.06.020"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.12110"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.06.005"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.01.005"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.04.006"},{"issue":"3","key":"e_1_3_4_55_1","first-page":"A3797","article-title":"Cardiorespiratoire verstoringen na 1e vaccinatie bij prematuur geboren kinderen: een prospectief cohortonderzoek [Cardiorespiratory events after first immunization in premature infants: a prospective cohort study]","volume":"156","author":"Buijs SC","year":"2012","unstructured":"Buijs SC, Boersma B. Cardiorespiratoire verstoringen na 1e vaccinatie bij prematuur geboren kinderen: een prospectief cohortonderzoek [Cardiorespiratory events after first immunization in premature infants: a prospective cohort study]. Ned Tijdschr Geneeskd. 2012;156 3 :A3797.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2059"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2011.0771"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.12.044"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001545"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2022.04.026"},{"key":"e_1_3_4_61_1","unstructured":"Kroger A Bahta L Hunter P General best practice guidelines for immunization. Best practices guidance of the Advisory Committee on Immunization Practices (ACIP). [Accessed 2022 Sep 8]. https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/downloads\/general-recs.pdf."},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.12316"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2004.052720"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcped.2009.09.009"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2023.2191575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T18:22:33Z","timestamp":1746814953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2023.2191575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,2]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,2]]}},"alternative-id":["10.1080\/21645515.2023.2191575"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2023.2191575","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-12-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2191575"}}